Rahika 200mg Tablet
By Rahika
Rx
12 Tablet in a Strip

Composition
Capmatinib(200mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
February, 2026

liver
When using Rahika 200mg Tablet, it is important to be cautious if you have liver disease. This medication may require a dose adjustment for patients with liver issues. It is advisable to consult your doctor before taking Rahika 200mg Tablet to ensure proper management of your condition.

kidney
Rahika 200mg Tablet is safe for patients with kidney disease. No dose adjustment is necessary.

alcohol
Consult your doctor when consuming alcohol with Rahika 200mg Tablet.

driving
It is not certain if Rahika 200mg Tablet affects driving ability. Avoid driving if you have symptoms that impact concentration and reaction time.

pregnancy
Rahika 200mg Tablet may not be safe to use during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Consult your doctor for advice.

breastfeeding
Rahika 200mg Tablet may not be safe during breastfeeding as there is limited evidence suggesting it can pass into breastmilk and potentially harm the baby.
| Habit Forming | No |
| Chemical Class | Quinazoline Derivative |
| Therapeutic Class | - |
| Action Class | Protein synthesis inhibitors |
₹14836.5
₹16485
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
